Comparative Genomic Analysis of a Clinical Isolate of Klebsiella quasipneumoniae subsp. similipneumoniae , a KPC-2 and OKP-B-6 Beta-Lactamases Producer Harboring Two Drug-Resistance Plasmids from Southeast Brazil
The aim of this study was to unravel the genetic determinants responsible for multidrug (including carbapenems) resistance and virulence in a clinical isolate of subsp. by whole-genome sequencing and comparative analyses. Eighty-three clinical isolates initially identified as carbapenem-resistant we...
Saved in:
Published in | Frontiers in microbiology Vol. 9; p. 220 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
16.02.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The aim of this study was to unravel the genetic determinants responsible for multidrug (including carbapenems) resistance and virulence in a clinical isolate of
subsp.
by whole-genome sequencing and comparative analyses. Eighty-three clinical isolates initially identified as carbapenem-resistant
were collected from nosocomial infections in southeast Brazil. After RAPD screening, the KPC-142 isolate, showing the most divergent DNA pattern, was selected for complete genome sequencing in an Illumina HiSeq 2500 instrument. Reads were assembled into scaffolds, gaps between scaffolds were resolved by
gap filling and extensive bioinformatics analyses were performed, using multiple comparative analysis tools and databases. Genome sequencing allowed to correct the classification of the KPC-142 isolate as
subsp.
. To the best of our knowledge this is the first complete genome reported to date of a clinical isolate of this subspecies harboring both class A beta-lactamases KPC-2 and OKP-B-6 from South America. KPC-142 has one 5.2 Mbp chromosome (57.8% G+C) and two plasmids: 190 Kbp
KQPS142a (50.7% G+C) and 11 Kbp
KQPS142b (57.3% G+C). The 3 Kbp region in
KQPS142b containing the
was found highly similar to that of
Kp13d of
Kp13 isolated in Southern Brazil in 2009, suggesting the horizontal transfer of this resistance gene between different species of
. KPC-142 additionally harbors an integrative conjugative element ICE
that could be involved in the mobilization of
KQPS142b and determinants of resistance to other classes of antimicrobials, including aminoglycoside and silver. We present the completely assembled genome sequence of a clinical isolate of
subsp.
, a KPC-2 and OKP-B-6 beta-lactamases producer and discuss the most relevant genomic features of this important resistant pathogen in comparison to several strains belonging to
subsp.
(phylogroup II-B),
subsp.
(phylogroup II-A),
(phylogroup I), and
(phylogroup III). Our study contributes to the description of the characteristics of a novel
subsp.
strain circulating in South America that currently represent a serious potential risk for nosocomial settings. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Elena Perrin, University of Florence, Italy; Christopher John Grim, United States Food and Drug Administration, United States Edited by: Daniela Ceccarelli, Wageningen Bioveterinary Research (WBVR), Netherlands These authors have contributed equally to this work. This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2018.00220 |